Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones

Author(s): Yulin Ren, Jianhua Yu, A. Douglas Kinghorn

Journal Name: Current Medicinal Chemistry

Volume 23 , Issue 23 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Sesquiterpene lactones are of considerable interest due to their potent bioactivities, including cancer cell cytotoxicity and antineoplastic efficacy in in vivo studies. Among these compounds, artesunate, dimethylaminoparthenolide, and L12ADT peptide prodrug, a derivative of thapsigargin, are being evaluated in the current cancer clinical or preclinical trials. Based on the structures of several antitumor sesquiterpene lactones, a number of analogues showing greater potency have been either isolated as natural products or partially synthesized, and some potential anticancer agents that have emerged from this group of lead compounds have been investigated extensively. The present review focuses on artemisinin, parthenolide, thapsigargin, and their naturally occurring or synthetic analogues showing potential anticancer activity. This provides an overview of the advances in the development of these types of sesquiterpene lactones as potential anticancer agents, including their structural characterization, synthesis and synthetic modification, and antitumor potential, with the mechanism of action and structure-activity relationships also discussed. It is hoped that this will be helpful in stimulating the further interest in developing sesquiterpene lactones and their derivatives as new anticancer agents.

Keywords: Artemisinin, Dimers of artemisinin, Dimethylaminoparthenolide, Parthenolide, Potential anticancer agents, Sesquiterpene lactones, Thapsigargin.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 22 August, 2016
Page: [2397 - 2420]
Pages: 24
DOI: 10.2174/0929867323666160510123255
Price: $65

Article Metrics

PDF: 86